For instance, CRC pathogenesis involves mutations in tumor suppressor (e.g., P53, APC) and oncogenes (e.g., KRAS), regulated post-transcriptionally by miRNAs, influencing diverse cancer pathways (197, 199–204). The gene discussed is TP53; the disease is colorectal carcinoma.